Skip to main content
SpringerLink
Log in

Novel device for preventing contrast-induced kidney injury cost saving

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was independent research funded by Osprey Medical Corporation.

Reference

  • Javanbakht M, et al. DyeVert PLUS EZ System for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost-Utility Analysis. PharmacoEconomics-Open : 27 Jan 2020. Available from: URL: https://doi.org/10.1007/s41669-020-00195-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Novel device for preventing contrast-induced kidney injury cost saving. Reactions Weekly 1790, 9 (2020). https://doi.org/10.1007/s40278-020-74628-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74628-z

Search

Navigation